Safety Issues: Clinical Trials

6 trials for Safety Issues, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 not yet recruiting. 6 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 16Completed 3, Unknown 2, Not yet recruiting 1

Follow Safety Issues: new trials by email Literature Review of Safety Issues trials Research Report on Safety Issues

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune)
rDEN2Δ30-7169 - Safety Issues, Dengue
Early Phase 1Not yet recruitingMahidol University122025-09-012025-04-03
Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients
KP405, Placebo - Safety Issues, Tolerance
Early Phase 1CompletedKariya Pharmaceuticals882024-08-012026-08-05
Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers
Nimodipine Injection, Nimodipine Injection (II) - Bioavailability, Safety Issues
Early Phase 1UnknownShenyang Dongxing Pharmaceutical Technology Co., Ltd.262018-08-232019-01-08
Safety and Pharmacokinetics of an Extract of Naringenin
Naringenin, Placebo - Safety Issues, Pharmacokinetics
Early Phase 1CompletedPennington Biomedical Research Center182018-05-252020-01-18
Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants
Lactoferrin/FOS - Safety Issues, Tolerance
Early Phase 1UnknownUniversity of Virginia202017-06-012017-05-22
Safety of Autologous Cord Blood Cells for Preterm Infants.
Autologous Umbilical Cord Blood Stem Cells Therapy - Safety Issues, Effect of Drugs
Early Phase 1CompletedGuangdong Women and Children Hospital152009-01-012020-06-02

Narrower conditions

Dengue (1)  ·  Perinatal Death (1)  ·  Viremia (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Arbovirus Infections (1)  ·  Death (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Flaviviridae Infections (1)  ·  Flavivirus Infections (1)  ·  Hemorrhagic Fevers, Viral (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Mosquito-Borne Diseases (1)  ·  Pregnancy Complications (1)  ·  RNA Virus Infections (1)  ·  Sepsis (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Nimodipine (1)  ·  naringenin (1)

Sponsors

Guangdong Women and Children Hospital (1)  ·  Kariya Pharmaceuticals (1)  ·  Mahidol University (1)  ·  Pennington Biomedical Research Center (1)  ·  Shenyang Dongxing Pharmaceutical Technology Co., Ltd. (1)  ·  University of Virginia (1)

Countries

China (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Candida Rebello (1)  ·  Ezanul A Wahab, MD (1)